Vital Farms, Inc. (NASDAQ:VITL - Get Free Report) insider Matthew Ohayer sold 25,000 shares of the company's stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $31.62, for a total transaction of $790,500.00. Following the completion of the transaction, the insider now owns 6,893,890 shares in the company, valued at $217,984,801.80. This trade represents a 0.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Matthew Ohayer also recently made the following trade(s):
- On Tuesday, June 17th, Matthew Ohayer sold 5,000 shares of Vital Farms stock. The stock was sold at an average price of $32.25, for a total value of $161,250.00.
- On Monday, April 21st, Matthew Ohayer sold 24,000 shares of Vital Farms stock. The shares were sold at an average price of $32.68, for a total value of $784,320.00.
- On Monday, March 24th, Matthew Ohayer sold 4,000 shares of Vital Farms stock. The stock was sold at an average price of $31.39, for a total value of $125,560.00.
- On Wednesday, March 19th, Matthew Ohayer sold 20,000 shares of Vital Farms stock. The shares were sold at an average price of $29.46, for a total value of $589,200.00.
Vital Farms Trading Up 0.6%
Vital Farms stock traded up $0.20 during trading hours on Friday, hitting $35.95. The stock had a trading volume of 709,861 shares, compared to its average volume of 1,030,731. The business's 50 day simple moving average is $33.49 and its 200-day simple moving average is $35.19. Vital Farms, Inc. has a one year low of $27.91 and a one year high of $48.41. The stock has a market cap of $1.60 billion, a price-to-earnings ratio of 32.19 and a beta of 0.89. The company has a quick ratio of 2.91, a current ratio of 3.35 and a debt-to-equity ratio of 0.03.
Vital Farms (NASDAQ:VITL - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.26 by $0.11. Vital Farms had a net margin of 8.26% and a return on equity of 19.53%. The business had revenue of $162.19 million during the quarter, compared to analyst estimates of $164.43 million. During the same quarter last year, the business earned $0.43 EPS. The firm's quarterly revenue was up 9.7% on a year-over-year basis. On average, equities analysts predict that Vital Farms, Inc. will post 1.11 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities analysts have commented on the stock. DA Davidson decreased their target price on shares of Vital Farms from $44.00 to $42.00 and set a "buy" rating on the stock in a report on Friday, March 14th. Telsey Advisory Group reissued an "outperform" rating and issued a $52.00 price objective on shares of Vital Farms in a research note on Monday, May 5th. Stifel Nicolaus upgraded Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 target price for the company in a research note on Friday, February 28th. Morgan Stanley reduced their target price on Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a report on Thursday, April 17th. Finally, BMO Capital Markets raised Vital Farms to a "strong-buy" rating in a report on Tuesday, May 6th. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Vital Farms has an average rating of "Buy" and a consensus price target of $44.63.
Check Out Our Latest Analysis on Vital Farms
Hedge Funds Weigh In On Vital Farms
A number of hedge funds have recently modified their holdings of the business. Osterweis Capital Management Inc. acquired a new stake in Vital Farms in the first quarter valued at $11,505,000. Inspire Investing LLC grew its position in shares of Vital Farms by 248.4% in the 1st quarter. Inspire Investing LLC now owns 37,460 shares of the company's stock valued at $1,141,000 after buying an additional 26,708 shares during the last quarter. Rhumbline Advisers increased its stake in shares of Vital Farms by 1.9% in the first quarter. Rhumbline Advisers now owns 47,317 shares of the company's stock valued at $1,442,000 after buying an additional 885 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Vital Farms by 1.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company's stock worth $2,739,000 after acquiring an additional 1,198 shares during the last quarter. Finally, Woodline Partners LP acquired a new position in shares of Vital Farms in the first quarter worth approximately $1,073,000. Institutional investors and hedge funds own 98.59% of the company's stock.
About Vital Farms
(
Get Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Read More

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.